Suppr超能文献

低钙、无镁钾心脏停搏液对缺血心肌的卓越保护作用。与圣托马斯医院停搏液对比的临床研究。

Superior protective effect of low-calcium, magnesium-free potassium cardioplegic solution on ischemic myocardium. Clinical study in comparison with St. Thomas' Hospital solution.

作者信息

Kinoshita K, Oe M, Tokunaga K

机构信息

Division of Cardiovascular Surgery, Kyushu University, Faculty of Medicine, Fukuoka, Japan.

出版信息

J Thorac Cardiovasc Surg. 1991 Apr;101(4):695-702.

PMID:2008108
Abstract

The protective effect of low-calcium, magnesium-free potassium cardioplegic solution on ischemic myocardium has been assessed in adult patients undergoing heart operations. Postreperfusion recovery of cardiac function and electrical activity was evaluated in 34 patients; 16 received low-calcium, magnesium-free potassium cardioplegic solution (group I) and 18 received St. Thomas' Hospital solution, which is enriched with calcium and magnesium (group II). There were no significant differences between the two groups in age, sex, body weight, and New York Heart Association functional class. Aortic occlusion time (107.3 +/- 46.8 minutes versus 113.6 +/- 44.3 minutes), highest myocardial temperature during elective global ischemia (11.5 degrees C +/- 3.1 degrees C versus 9.3 degrees C +/- 3.2 degrees C), and total volume of cardioplegic solution (44.2 +/- 20.5 ml/kg versus 43.4 +/- 17.6 ml/kg) were also similar in the two groups. On reperfusion, electrical defibrillation was required in four cases (25.5%) in group I and in 15 cases (83.3%) in group II (p less than 0.005), and bradyarrhythmias were significantly more prevalent in group II (6.3% versus 44.4%; p less than 0.05). Serum creatine kinase MB activity at 15 minutes of reperfusion (12.3 +/- 17.0 IU/L versus 42.6 +/- 46.1 IU/L; p less than 0.05) and the dose of dopamine or dobutamine required during the early phase of reperfusion (1.8 +/- 2.5 micrograms/kg/min versus 6.1 +/- 3.3 micrograms/kg/min; p less than 0.0002) were both significantly greater in group II. Postischemic left ventricular function, as assessed by percent recovery of the left ventricular end-systolic pressure-volume relationship in patients who underwent aortic valve replacement alone, was significantly better in group I (160.4% +/- 45.5% versus 47.8% +/- 12.9%; p less than 0.05). Serum level of calcium and magnesium ions was significantly lower in group I. Thus low-calcium, magnesium-free potassium cardioplegic solution provided excellent protection of the ischemic heart, whereas St. Thomas' Hospital solution with calcium and magnesium enabled relatively poor functional and electrical recovery of the heart during the early reperfusion period. These results might be related to differing levels of extracellular calcium and magnesium on reperfusion.

摘要

低钙、无镁钾心脏停搏液对缺血心肌的保护作用已在接受心脏手术的成年患者中进行了评估。对34例患者进行了再灌注后心脏功能和电活动恢复情况的评估;16例接受低钙、无镁钾心脏停搏液(I组),18例接受富含钙和镁的圣托马斯医院停搏液(II组)。两组在年龄、性别、体重和纽约心脏协会心功能分级方面无显著差异。两组的主动脉阻断时间(107.3±46.8分钟对113.6±44.3分钟)、选择性全心缺血期间的最高心肌温度(11.5℃±3.1℃对9.3℃±3.2℃)以及心脏停搏液总量(44.2±20.5ml/kg对43.4±17.6ml/kg)也相似。再灌注时,I组4例(25.5%)需要电除颤,II组15例(83.3%)需要电除颤(p<0.005),II组缓慢性心律失常明显更常见(6.3%对44.4%;p<0.05)。再灌注15分钟时血清肌酸激酶MB活性(12.3±17.0IU/L对42.6±46.1IU/L;p<0.05)以及再灌注早期所需多巴胺或多巴酚丁胺的剂量(1.8±2.5μg/kg/min对6.1±3.3μg/kg/min;p<0.0002)在II组均显著更高。对于仅接受主动脉瓣置换术的患者,通过左心室收缩末期压力-容积关系的恢复百分比评估的缺血后左心室功能,I组明显更好(160.4%±45.5%对47.8%±12.9%;p<0.05)。I组血清钙和镁离子水平显著较低。因此,低钙、无镁钾心脏停搏液对缺血心脏提供了极好的保护,而含镁和钙的圣托马斯医院停搏液在再灌注早期使心脏的功能和电恢复相对较差。这些结果可能与再灌注时细胞外钙和镁的不同水平有关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验